GB9914057D0 - Antibody therapy - Google Patents

Antibody therapy

Info

Publication number
GB9914057D0
GB9914057D0 GBGB9914057.6A GB9914057A GB9914057D0 GB 9914057 D0 GB9914057 D0 GB 9914057D0 GB 9914057 A GB9914057 A GB 9914057A GB 9914057 D0 GB9914057 D0 GB 9914057D0
Authority
GB
United Kingdom
Prior art keywords
antibody therapy
antibody
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9914057.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KS Biomedix Ltd
Original Assignee
KS Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KS Biomedix Ltd filed Critical KS Biomedix Ltd
Priority to GBGB9914057.6A priority Critical patent/GB9914057D0/en
Publication of GB9914057D0 publication Critical patent/GB9914057D0/en
Priority to AU54157/00A priority patent/AU5415700A/en
Priority to PCT/GB2000/002351 priority patent/WO2000076453A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
GBGB9914057.6A 1999-06-16 1999-06-16 Antibody therapy Ceased GB9914057D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9914057.6A GB9914057D0 (en) 1999-06-16 1999-06-16 Antibody therapy
AU54157/00A AU5415700A (en) 1999-06-16 2000-06-16 Emzyme-assisted cell death
PCT/GB2000/002351 WO2000076453A2 (en) 1999-06-16 2000-06-16 Emzyme-assisted cell death

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9914057.6A GB9914057D0 (en) 1999-06-16 1999-06-16 Antibody therapy

Publications (1)

Publication Number Publication Date
GB9914057D0 true GB9914057D0 (en) 1999-08-18

Family

ID=10855492

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9914057.6A Ceased GB9914057D0 (en) 1999-06-16 1999-06-16 Antibody therapy

Country Status (3)

Country Link
AU (1) AU5415700A (en)
GB (1) GB9914057D0 (en)
WO (1) WO2000076453A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528761D0 (en) * 1985-11-22 1985-12-24 Axon Healthcare Ltd Enzyme-coupled antibodies

Also Published As

Publication number Publication date
WO2000076453A2 (en) 2000-12-21
WO2000076453A3 (en) 2001-08-02
AU5415700A (en) 2001-01-02

Similar Documents

Publication Publication Date Title
HK1200316A1 (en) Therapeutic microfoams
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
GB9911569D0 (en) Antibodies
GB0028429D0 (en) Therapy
GB9909064D0 (en) Therapies
GB9903584D0 (en) Modified calycins
GB9930570D0 (en) Therapy
GB9911881D0 (en) Therapeutic agents
GB9907243D0 (en) Therapy
GB9816556D0 (en) Therapy
GB9911802D0 (en) Therapeutic combination
GB9903476D0 (en) Therapeutic agents
GB9911803D0 (en) Therapeutic combination
GB9911804D0 (en) Therapeutic combination
GB9903119D0 (en) Therapeutic agents
EP1170018A4 (en) Ligand-bonded complex
GB9914742D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
GB9915419D0 (en) Antigens
GB9914743D0 (en) Therapeutic agents
GB9914057D0 (en) Antibody therapy
GB9927698D0 (en) Therapeutic antibody
GB9929923D0 (en) Antigen preparations
GB9921063D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)